Skip to main content

UK Supports Three-Parent IVF

Parliament today voted to allow techniques that could help couples produce babies with a reduced chance of passing on heritable mitochondrial diseases.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

WIKIMEDIA, MICHIEL1972The UK government today (February 3) voted 382 to 128 in favor of allowing mitochondrial donation for the purposes of producing embryos using genetic material from three different parents. Such mitochondrial replacement techniques would allow women with mitochondrial disease to increase the chances of bearing healthy children through in vitro fertilization (IVF).

“This is really good news—it’s a triumph of common sense really,” Alastair Kent, director of the national charity Genetic Alliance UK, told The Verge. “It’s one of those occasions when creating a regulatory framework that allows for the appliance of science for the benefit of people who live in insurmountable circumstances has made a real difference.”

Last June, the U.K.’s Human Fertilization and Embryology Authority (HFEA) released a report stating that the techniques are “not unsafe,” and HFEA panel member Robin Lovell-Badge, a researcher with the Medical Research Council (MRC), estimated that, given the additional experimentation that was still needed, the techniques would be approved within two years.

Now, just eight months later, Parliament has taken the first step toward approving the techniques, making Britain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen